Series B Completed
Gate Bioscience Series B
A$65m raised
Announced 16 Nov 2025 (approx.)
Investors
Led by
With
- Eli Lilly and Company
- Versant Ventures · Existing investor
- Andreessen Horowitz · Existing investor
- GV · Existing investor
- ARCH Venture Partners · Existing investor
Investors as the sources name them; a linked name has a FundComb profile. An existing investor is one the source says followed on.
- Company
- Gate Bioscience
- Stage
- Series B
- Amount raised
- A$65m
- Company based in
- Australia
Similar rounds
- ENA Respiratory Series B Oct 2025 · A$34.5m
- AutoGrab Series B Dec 2025 · led by Movac
- Heidi Series B Oct 2025 · A$100m · led by Point72
- ProcurePro Series B May 2026 · A$15m · led by QIC Ventures
- Agentio Series B Nov 2025 · A$61.1m · led by Forerunner Ventures